DeRemer CE, Vouri SM, Guo J, Donahoo WT, et al. Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: A retrospective cohort study. J Diabetes Complications 2021 Jun 11:107972.
PMID: 34247911